Occult rifampicin-resistant tuberculosis: better assays are needed

Affiliations

¹ Department of Medicine, University of the Witwatersrand, Johannesburg, Gauteng, South Africa; Klerksdorp Tshepong Hospital Complex, Klerksdorp, North West Province, South Africa; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, Gauteng, South Africa. Electronic address: variava@worldonline.co.za.
² Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, Gauteng, South Africa.

Comment

Ebrahim Variava et al. Lancet Infect Dis. 2018 Dec.

. 2018 Dec;18(12):1293-1295.

doi: 10.1016/S1473-3099(18)30550-4. Epub 2018 Oct 18.

¹ Department of Medicine, University of the Witwatersrand, Johannesburg, Gauteng, South Africa; Klerksdorp Tshepong Hospital Complex, Klerksdorp, North West Province, South Africa; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, Gauteng, South Africa. Electronic address: variava@worldonline.co.za.
² Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, Gauteng, South Africa.

No abstract available

Comment on

Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.
Makhado NA, Matabane E, Faccin M, Pinçon C, Jouet A, Boutachkourt F, Goeminne L, Gaudin C, Maphalala G, Beckert P, Niemann S, Delvenne JC, Delmée M, Razwiedani L, Nchabeleng M, Supply P, de Jong BC, André E. Makhado NA, et al. Lancet Infect Dis. 2018 Dec;18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. Epub 2018 Oct 18. Lancet Infect Dis. 2018. PMID: 30342828